description Johnson & Johnson (JNJ) Overview
Johnson & Johnson is a large-cap, blue chip stock within the healthcare sector. The company’s diversified business—encompassing pharmaceuticals, medical devices, and consumer health products—makes it a stable investment. It's notable for its long history of consistent dividend payments, earning it the title “Dividend King.” This stock is typically suitable for investors seeking reliable income and exposure to established pharmaceutical and healthcare industries.
help Johnson & Johnson (JNJ) FAQ
Does Johnson & Johnson pay a reliable dividend?
Yes, Johnson & Johnson is famously known for consistently distributing dividends to shareholders and is a popular Dividend King. It has increased its dividend payout for over 60 consecutive years, maintaining a substantial market capitalization.
How did the Kenvue spin-off affect Johnson & Johnson?
In 2023, Johnson & Johnson spun off its consumer health division, which includes brands like Tylenol and Band-Aid, into a new publicly traded company called Kenvue. This move allowed JNJ to focus heavily on its higher-growth pharmaceutical and medical device sectors.
What are the main business segments of Johnson & Johnson?
JNJ generates its revenue through two primary sectors after the Kenvue separation: pharmaceuticals and medical devices. The company remains a diversified healthcare giant with a massive global footprint.
Is JNJ considered a defensive stock?
As a diversified healthcare company with steady cash flow and essential medical products, many analysts consider it a relatively stable blue-chip stock. Its long history of dividend growth provides a steady income stream for conservative investors.
explore Explore More
Similar to Johnson & Johnson (JNJ)
See all arrow_forward
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
